Comparative evaluation of the clinicoeconomic efficiency of treatment in patients with tuberculosis at hospital and when using hospital replacement technologies

• Main Authors: Yu. M. Markelov, Yu. S. Kononenko, M. R. Voishnis, L. V. Doeva
• Format: Article
• Language: Russian
• Published: NEW TERRA Publishing House 2015-02-01
• Series: Tuberkulez i Bolezni Lëgkih
• Subjects: tuberculosis; clinicoeconomic efficiency; hospital replacement technologies
• Online Access: https://www.tibl-journal.com/jour/article/view/338

The clinicoeconomic efficiency of Stage 1 chemotherapy (CT) using different organizational forms of treatment was comparatively evaluated in 172 patients with new-onset pulmonary tuberculosis. The main reasons for ineffective CT were discontinued treatment (27.1 to 10.5%) and a fatal outcome (13.8% at an around-the-clock hospital). Home hospital treatment showed the lowest rate of discontinued and refused treatments (10.5%). The cost of Stage 1 CT (90 bed-days) at an around-the-clock hospital was 49,339 rubles. The highest clinicoeconomic efficiency of Stage 1 CT was noted during home hospital treatment: the rate of discontinued treatment was 2.3-2.5 times lower than that at a day hospital and around-the-clock hospital and the cost of ceased bacterial discharge verified by sputum microscopy was 8,501 rubles, which was 6.2 times less than that at an around-the-clock hospital and almost less than that at a day hospital.